fda warning about semaglutide letter compounding news Navigating Compounded Semaglutide: What Health Care Providers Need to Know FDA Issues Warning Letters to – FDA warns about semaglutide overdoses,

141 They remain in the body, interacting with GLP-1 receptors in various organs, which could lead to DDIs through mechanisms of action such as slowing gastric emptying, reducing fat mass and inflammation, and increasing glomerular filtration rate (GFR) and renal plasma flow, consequently altering the pharmacokinetics of the victim drug (Figure 3)

Semaglutide should reduce appetite, not eliminate eating

If the ice packs lasted 24-30 hours (which is typical), the medication may have been without active cooling for 14-20 hours

5mg in 2.5ml (2mg/ml concentration) A middle ground between the 2ml and 3ml reconstitutions

Ozempic was FDA-approved in 2017 after being tested on patients with type 2 diabetes for safely lowering A1c average blood sugar levels